Pediatrics Doctors in Kennett Square, PA Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Dr. Paula D. Brenn, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 731 W Cypress St, Kennett Square, PA 19348 Phone: 610-444-7550    Fax: 610-444-4656

Jacquelyn Detweiler, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 891 E Baltimore Pike, Kennett Square, PA 19348 Phone: 610-444-0113    Fax: 610-444-0744

Dr. Henry Karcsh, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 891 E Baltimore Pike, Kennett Square, PA 19348 Phone: 610-444-0113    Fax: 610-444-0744

Dr. Elaine Gonzalez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 891 E Baltimore Pike, Kennett Square, PA 19348 Phone: 610-444-0113    Fax: 610-444-0744

Dr. Venita Kaul, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 891 East Baltimore Pike, Kennett Square, PA 19348 Phone: 610-444-0113    Fax: 610-444-0744

Dr. Carol Lynne Marsh, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 630 Cope Road, Suite E, Kennett Square, PA 19348 Phone: 610-444-5573    Fax: 610-444-0991

Dr. Jennifer Lynn Shrager, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 345 Scarlet Road, Suite 12, Kennett Square, PA 19348 Phone: 610-444-1884    Fax: 610-444-1894

Sumathi Sundar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 817 E Baltimore Pike Ste A, Kennett Square, PA 19348 Phone: 610-444-0113    Fax: 610-444-0744

News Archive

Optibrium to integrate ChemAxon's Plexus with StarDrop software platform

Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.

Phase II study of OPAXIO to be revealed

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).

Research findings reveal new approach to prevent age-related obesity

The function and distribution of adipose tissue in the body change during the course of life. Beige fat cells, a special type of adipocytes, have the capability to use energy reserves - fatty deposits - by generating heat in a process known as thermogenesis.

Patient satisfaction a poor proxy for quality of care in elective cranial neurosurgery

Patient satisfaction is a very poor proxy for quality of care comparisons in elective cranial neurosurgery. Because deaths are rare events in elective cranial neurosurgery, reporting of surgeon or even department-specific mortality figures cannot differentiate a high or low level of the quality of care.

CBSM intervention can alter tumor-promoting processes in women with breast cancer

A team of researchers led by Michael H. Antoni, director of the Center for Psycho-Oncology Research at the University of Miami (UM) has shown that a stress management program tailored to women with breast cancer can alter tumor-promoting processes at the molecular level. The new study recently published in the journal Biological Psychiatry is one of the first to link psychological intervention with genetic expression in cancer patients.

Read more Medical News

› Verified 9 days ago